Lucía Gutiérrez-Chamorro et al (2021) reported a decreased level of ACE2 mRNA in nasopharyngeal swabs of COVID-19 patients on day 3 compared to day 1 [51]. This evidence concerns the gene ACE2 and COVID-19.